Aptus Endosystems' Heli-FX System gains CE mark
Top Story
By: Katie Bell
Ref: Business Wire
Published: 04/02/2013
Aptus Endosystems announced on Tuesday that its thoracic-length Heli-FX System received CE mark. The company noted that the device, which is similar to the original system that gained CE mark in May 2011, is designed for treating abdominal aortic aneurysms. However, the new system consists of a longer delivery device with additional tip configurations to bring the helical EndoAnchor technology to the treatment of thoracic aortic aneurysms (TAA).
The implantable EndoAnchor enables independent endograft fixation, designed to replicate the sealing and fixation of hand suturing, the company said. Further, the device maker remarked that the system can be used during de novo thoracic endovascular aneurysm repair (TEVAR) procedures.
Aptus Endosystems said that the device, which received FDA approval in September last year, can be used with Cook Medical’s Zenith TX2, Jotec’s E-Vita, W.L. Gore’s TAG and Medtronic’s Talent Thoracic and Valiant endografts in both initial implant and secondary repair settings.
The implantable EndoAnchor enables independent endograft fixation, designed to replicate the sealing and fixation of hand suturing, the company said. Further, the device maker remarked that the system can be used during de novo thoracic endovascular aneurysm repair (TEVAR) procedures.
Aptus Endosystems said that the device, which received FDA approval in September last year, can be used with Cook Medical’s Zenith TX2, Jotec’s E-Vita, W.L. Gore’s TAG and Medtronic’s Talent Thoracic and Valiant endografts in both initial implant and secondary repair settings.